Financial Statements — AMIX
Balance Sheet
(in millions USD)| Metric | Q3
2026 | Q2
2026 | Q1
2026 | Q3
2025 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Cash & Equivalents | 9.93 | 7.48 | 8.59 | 11.82 | 1.22 | 5.16 | 6.75 |
| Total Current Assets | 10.19 | 7.89 | 8.98 | 11.93 | 1.69 | 5.35 | 7.08 |
| Property, Plant & Equipment | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 |
| Total Non-current Assets | 0.02 | 0.04 | 0.02 | 0.02 | 0.12 | 0.02 | 0.02 |
| Total Assets | 10.21 | 7.93 | 9.00 | 11.95 | 1.81 | 5.37 | 7.10 |
| Accounts Payable | 0.71 | 0.84 | 0.82 | 0.23 | 0.66 | 0.57 | 0.29 |
| Short-term Debt | -- | -- | -- | 1.13 | -- | -- | -- |
| Total Current Liabilities | 1.65 | 1.49 | 1.97 | 2.25 | 0.97 | 1.26 | 0.76 |
| Long-term Debt | -- | -- | -- | -- | 1.46 | -- | -- |
| Total Non-current Liabilities* | 0.00 | 0.00 | 0.00 | 0.00 | 6.43 | 1.09 | 1.04 |
| Total Liabilities | 1.65 | 1.49 | 1.97 | 2.25 | 7.40 | 2.34 | 1.81 |
| Retained Earnings | (64.43) | (61.17) | (53.72) | (47.19) | (33.56) | (44.47) | (41.67) |
| Total Stockholder Equity | 8.56 | 6.45 | 7.03 | 9.71 | (5.59) | 3.03 | 5.29 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q4
2026 | Q3
2026 | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Research & Development | 1.46 | 1.72 | 2.37 | 1.59 | 1.55 | 1.04 | 0.79 | 0.60 | 1.17 | 0.95 |
| Selling, General & Admin | 1.28 | 1.62 | 5.17 | 1.83 | 1.70 | 1.70 | 1.63 | 2.32 | 1.66 | 1.80 |
| Total Operating Expenses | 2.74 | 3.34 | 7.53 | 3.42 | 3.25 | 2.75 | 2.42 | 2.92 | 2.84 | 2.75 |
| Operating Income | (2.74) | (3.34) | (7.53) | (3.42) | (3.25) | (2.75) | (2.41) | (2.92) | (2.84) | (2.75) |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | 0.03 | -- | -- |
| Pretax Income | (2.67) | (3.26) | (7.45) | (3.34) | (3.19) | (2.71) | (5.41) | (3.11) | (2.81) | (2.70) |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | (2.67) | (3.26) | (7.45) | (3.34) | (3.19) | (2.71) | (5.41) | (3.11) | (2.81) | (2.70) |
| Basic EPS | 0.49 | (0.36) | (1.38) | (1.07) | (0.74) | (1.46) | 8.03 | (0.23) | (2.47) | (0.14) |
| Diluted EPS | -- | -- | -- | -- | -- | -- | -- | (0.23) | -- | -- |
Cash Flow Statement
(in millions USD)| Metric | Q4
2026 | Q3
2026 | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Operating Cash Flow | (2.89) | (2.97) | (3.82) | (2.60) | (2.55) | (5.75) | (2.29) | (4.36) | (1.60) | (1.85) |
| Capital Expenditures | 0.00 | 0.01 | 0.00 | 0.00 | -- | 0.01 | 0.00 | 0.02 | 0.00 | 0.01 |
| Free Cash Flow* | (2.89) | (2.98) | (3.82) | (2.60) | -- | (5.76) | (2.29) | (4.38) | (1.60) | (1.86) |
| Investing Cash Flow | -0.00 | (0.01) | 0.00 | 0.00 | -- | (0.01) | -0.00 | (0.02) | 0.00 | -0.00 |
| Financing Cash Flow | (0.04) | 5.43 | 2.71 | 2.06 | -- | 8.97 | 9.68 | 1.65 | 0.00 | 0.00 |
* Derived from reported values